|
Volumn 154, Issue 6, 2006, Pages 921-922
|
Xenotransplantation of pig islets into Mexican children: Were the fundamental ethical requirements to proceed with such a study really met? [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INSULIN;
ALLOTRANSPLANTATION;
BIOSAFETY;
CHILD;
CLINICAL TRIAL;
HEALTH CARE ORGANIZATION;
HUMAN;
INFECTION RISK;
INFORMED CONSENT;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
LETTER;
MEDICAL ETHICS;
MEXICO;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PATIENT RIGHT;
PRIORITY JOURNAL;
QUALITY CONTROL;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SWINE;
XENOTRANSPLANTATION;
ANIMALS;
CHILD;
CLINICAL TRIALS;
DIABETES MELLITUS, TYPE 1;
HUMANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
MEXICO;
SWINE;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 33745698782
PISSN: 08044643
EISSN: None
Source Type: Journal
DOI: 10.1530/eje.1.02142 Document Type: Letter |
Times cited : (11)
|
References (6)
|